R&D accounting treatment, firm performance, and market value: Biotech firms case study

R&D accounting treatment, firm performance, and market value: Biotech firms case study

Bibliographic Details
Main Author:	Namryoung Lee
Format:	Article
Language:	English
Published:	Centre of Sociological Research, Szczecin, Poland 2019-05-01
Series:	Journal of International Studies
Subjects:	R&D accounting treatment decrease in R&D capitalization biotech market value
Online Access:	https://www.jois.eu/?513,en_rd-accounting-treatment-firm-performance-and-market-value-biotech-firms-case-study

Similar Items

R&D Accounting Treatment, R&D State and Tax Avoidance: With a Focus on Biotech Firms
by: Namryoung Lee
Published: (2018-12-01)

Differentiation Strategy, R&D Intensity, and Sustainability of Accounting Earnings: With a Focus on Biotech Firms
by: Namryoung Lee, et al.
Published: (2019-03-01)

R & D Intensity and Dividend Policy: Evidence from South Korea’s Biotech Firms
by: Namryoung Lee, et al.
Published: (2019-09-01)

International Strategy, R&D Intensity, and Sustainable Earnings of Biotech Firms
by: Jaehong Lee, et al.
Published: (2019-09-01)

Evidence of mispricing for South African listed R&D firms contributed by accounting conservatism
by: Tai-Lin G. Chen, et al.
Published: (2017-02-01)

R&D Activity Investments and Macroeconomic Determinant Factors : A Firm-level Investigation of Two Segments of the Electronic Industry in Sweden
by: Gardell, Pierre
Published: (2013)

Accounting Treatment of R&D for Environmentally Responsible Firms: Evidence from South Korea
by: Suyon Kim, et al.
Published: (2020-04-01)

What Finance Can Learn from Biopharma Industry: A Transfer of Innovation Models
by: Francesco COREA
Published: (2015-12-01)

R&D, Patents and Firm Value : The Effects of Intellectual Property and Innovation on Firms' Market Values
by: Kuzikaite, Violeta Andzelina
Published: (2013)

External Financing, R&D Intensity, and Firm Value in Biotechnology Companies
by: Namryoung Lee, et al.
Published: (2019-07-01)

Research and Development and Firm Performance : Investigating the need for Research and Development Expenditure as a factor of enhancing the Performance of Firms
by: Ayam, Rufus
Published: (2012)

Is Implementing a Biotech Ban Correct or Not? Analysis of Farmer Perceptions and Attitudes on the Philippine Supreme Court’s Ban on Biotech Crops
by: Florendo Aala, W.Jr, et al.
Published: (2022)

Corporate liquidity and firm value: evidence from China’s listed firms
by: Du Jinmin, et al.
Published: (2016-01-01)

Determinants of Financing Decisions in Innovative Firms: A Review on Theoretical Backgrounds and Empirical Evidence
by: Mihaela Diaconu
Published: (2016-01-01)

The Impact of the Disclosed R & D Expenditure on the Value Relevance of the Accounting Information: Evidence from Greek Listed Firms
by: Petros Kalantonis, et al.
Published: (2020-05-01)

Management accounting and control systems used by R&D intensive firms in different organizational life-cycle stages
by: Silvola, H. (Hanna)
Published: (2007)

The Effect of Intellectual Property on the Market Value of Firms : Evidence of R&D, Patent, Trademark and Design from Swedish Firms
by: Ekman, Anton, et al.
Published: (2018)

R&D Investments and Firm Value: Evidence from China
by: Woo Sung Kim, et al.
Published: (2018-11-01)

Intellectual Capital and Financial Performance of Biotech Companies in the Pharmaceutical Industry
by: Ion Anghel, et al.
Published: (2018-08-01)

Firm-level human capital and innovation: evidence from China
by: Sun, Xiuli
Published: (2015)

Exploring Business Models for SMEs in the Biotech Industry
by: Holm-Bergqvist, Linus, et al.
Published: (2013)

Local context and firms creation
by: Mariasole Bannò, et al.
Published: (2020-09-01)

R&D AND PRODUCTIVITY IN THE SPANISH´S MANUFACTURING FIRMS
by: Desiderio Romero Jordán, et al.
Published: (2009-12-01)

Market Evaluation of the Value of Patent
by: Youn, Tae hoon
Published: (2004-12-01)

Analyzing the Interaction between R&D Subsidies and Firm’s Innovation Strategy
by: Sergio Moises Afcha
Published: (2012-09-01)

Do Patents Lead to an Increase in Firm Value? Evidence from Korea
by: LEE, JANGWOOK
Published: (2020-08-01)

Choosing R&D or advertising for competing firms in uncertain market
by: Bo Xie, et al.
Published: (2014-06-01)

Strategic R&D risk choices of public and private firms
by: Mingqing Xing
Published: (2019-01-01)

How brand equity affects firm productivity: The role of R&D and human capital
by: Qiuqin He, et al.
Published: (2020-01-01)

Påverkar grundaren aktiekursens utveckling efter en IPO? : En studie av svenska biotech-bolag
by: Gabrielsson, Oliver, et al.
Published: (2018)

Advertising, research and development, and capital market risk: higher risk firms versus lower risk firms
by: Miao-Ling Chen, et al.
Published: (2012-09-01)

Inflation and innovation value: how inflation affects innovation and the value strategy across firms
by: Leonardo Andrade Rocha, et al.
Published: (2021-02-01)

Essays on Firm Growth and Survival as a Fortune 500 Firm
by: Vadakkepatt, Gautham Gopal
Published: (2011)

The impact of alliances and internal R&D on the firm's innovation and financial performance
by: Fábio de Oliveira Paula, et al.
Published: (2018-01-01)

Value Relevance of R&D expenses in capital market: A study of brazilian IT sector companies
by: Ronan Reis Marçal, et al.
Published: (2020-04-01)

The Business Model of Biotech SMEs : How do biotech SMEs cope with the industry’s challenges?
by: Tölle, Julian, et al.
Published: (2016)

Corporate Social Responsibility and Firm Value: The Moderating Effects of Financial Flexibility and R&D Investment
by: Zhaoyang Guo, et al.
Published: (2020-10-01)

Does R&D Expenditure with Heavy Related Party Transactions Harm Firm Value?
by: Sangil Kim, et al.
Published: (2017-07-01)

Ambivalent impact of customer satisfaction on firm value in emerging markets: the case of Korea
by: Hyunseok Kim, et al.
Published: (2017-04-01)

Distribution and effect of R&D subsidies: A comparative analysis according to firm size
by: Lliana Herrera, et al.
Published: (2010-10-01)